Menu Search
Equities

Shanghai Haixin Group Co Ltd

900917:SHH

Shanghai Haixin Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.211
  • Today's Change-0.003 / -1.40%
  • Shares traded653.35k
  • 1 Year change-29.19%
  • Beta--
Data delayed at least 15 minutes, as of Sep 23 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai Haixin Group Co., Ltd. is a China based company principally engaged in the production and sales of textile products and pharmaceuticals. The Company operates its business through two segments. The Textile segment is mainly engaged in the production and sales of plush fabric and clothing. The Pharmaceutical segment is mainly engaged in the manufacture and sales of pharmaceutical products. In addition, The Company is also engaged in financial investment business and industrial plant rental management business. The Company operates its business in the domestic market and overseas markets.

  • Revenue in CNY (TTM)963.91m
  • Net income in CNY166.14m
  • Incorporated1993
  • Employees760.00
  • Location
    Shanghai Haixin Group Co LtdNo.688 Changxing RoadDongjing Town, Songjiang DistrictSHANGHAI 200001ChinaCHN
  • Phone+86 2 163917000
  • Fax+86 2 163917678
  • Websitehttp://www.haixin.com.cn
More ▼

Institutional shareholders

3.79%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Jul 202417.14m3.66%
SSgA Funds Management, Inc.as of 05 Sep 2024515.42k0.11%
Vanguard Global Advisers LLCas of 31 Aug 202498.44k0.02%
Geode Capital Management LLCas of 31 Jul 20248.40k0.00%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.